⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMRN News
BioMarin Pharmaceuticals Inc
4D Path Announces Strategic Financing and Appointment of Katherine Vega Stultz and Robert J. Hombach to Its Board of Directors
businesswire.com
BMRN
BAX
Form 8-K
sec.gov
XYZ
BSQKZ
PINS
BMRN
LEVI
Form 8-K
sec.gov
BMRN
BioMarin Reports First Quarter 2026 Financial and Operating Results
prnewswire.com
BMRN
BioMarin Presents New Data on the Effect of Long-Term Treatment with VOXZOGO® (vosoritide) on Arm Span, Bone Health and Growth in Children With Achondroplasia at the Pediatric Endocrine Society's 2026 Annual Meeting
prnewswire.com
BMRN
Form 8-K
sec.gov
BMRN
BioMarin Completes Acquisition of Amicus Therapeutics
prnewswire.com
BMRN
Form 8-K
sec.gov
BMRN
Form 8-K
sec.gov
FOLD
BMRN
BioMarin Announces Board Leadership Transition
prnewswire.com
BMRN